Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Profitable Stocks We Steer Clear Of

By: StockStory

July 21, 2026 at 00:33 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

RVLV Cover Image

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here are three profitable companies to avoid and some better opportunities instead.

Revolve (RVLV)

Trailing 12-Month GAAP Operating Margin: 5.9%

Launched in 2003 by software engineers Michael Mente and Mike Karanikolas, Revolve (NYSE: RVLV) is a fashion retailer leveraging social media and a community of fashion influencers to drive its merchandising strategy.

Why Do We Think RVLV Will Underperform?

Competition may be pulling attention away from its platform as its 5.8% average growth in active customers was choppy
High marketing expenses suggest it needs to spend heavily on new customer acquisition to sustain momentum
Earnings growth underperformed the sector average over the last three years as its EPS grew by just 7.5% annually

At $25.94 per share, Revolve trades at 14.9x forward EV/EBITDA. To fully understand why you should be careful with RVLV, check out our full research report (it’s free).

Biogen (BIIB)

Trailing 12-Month GAAP Operating Margin: 18.9%

Founded in 1978 and pioneering treatments for some of medicine's most complex challenges, Biogen (NASDAQ: BIIB) develops and markets therapies for neurological conditions, including multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and rare diseases.

Why Are We Hesitant About BIIB?

Annual sales declines of 4.6% for the past five years show its products and services struggled to connect with the market during this cycle
Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 11.4% annually, worse than its revenue
Waning returns on capital imply its previous profit engines are losing steam

Biogen’s stock price of $200.23 implies a valuation ratio of 17x forward P/E. Check out our free in-depth research report to learn more about why BIIB doesn’t pass our bar.

Oaktree Specialty Lending (OCSL)

Trailing 12-Month GAAP Operating Margin: 47.2%

Managed by Oaktree Capital Management, one of the world's premier alternative investment firms, Oaktree Specialty Lending (NASDAQ: OCSL) is a business development company that provides customized financing solutions to mid-market companies across various industries.

Why Should You Sell OCSL?

Customers postponed purchases of its products and services this cycle as its revenue declined by 13.2% annually over the last two years
Sales were less profitable over the last two years as its earnings per share fell by 18.9% annually, worse than its revenue declines
Products and services are facing significant credit quality challenges during this cycle as tangible book value per share has declined by 5.9% annually over the last five years

Oaktree Specialty Lending is trading at $12.10 per share, or 8.8x forward P/E. Dive into our free research report to see why there are better opportunities than OCSL.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	247.55	-2.44 (-0.98%)
AAPL	327.74	+1.15 (0.35%)
AMD	544.43	+40.86 (8.11%)
BAC	61.22	+0.80 (1.32%)
GOOG	346.19	-5.18 (-1.47%)
META	643.81	-2.04 (-0.32%)
MSFT	397.75	-4.54 (-1.13%)
NVDA	207.29	+4.01 (1.97%)
ORCL	127.05	+5.67 (4.67%)
TSLA	378.93	+9.36 (2.53%)